RETRACTION: "A microporous roust La(III)-organic framework for cyanosilylation reactions and treatment effect on tuberculosis by activating the PI3K-AKT signaling pathway in immune cells" (Retraction of Vol 13, Pg 5890, 2020)

被引：0

作者：

Yan, Liping ^{[1
]}

Sun, Qin ^{[1
]}

Liu, Zhibin ^{[1
]}

Wu, Min ^{[1
]}

Liang, Li ^{[1
]}

Zhang, Qing ^{[1
]}

机构：

[1] Tongji Univ, Shanghai Pulm Hosp, Clin & Res Ctr TB, Sch Med,Shanghai Key Lab TB, Shanghai, Peoples R China

来源：

ARABIAN JOURNAL OF CHEMISTRY | 2023年 / 16卷 / 04期

关键词：

D O I：

10.1016/j.arabjc.2023.104651

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

引用

页数：1

共 48 条

[31] RETRACTION: Loss of miR-204-5p Promotes Tumor Proliferation, Migration, and Invasion Through Targeting YWHAZ/PI3K/AKT Pathway in Esophageal Squamous Cell Carcinoma (Retraction of Vol 13, Pg 4679, 2020)
Shen, Z.
Chai, T.
Luo, F.
ONCOTARGETS AND THERAPY, 2023, 16 : 801 - 801
[32] RETRACTION: G-5555 synergized miR-485-5p to alleviate cisplatin resistance in ovarian cancer cells via Pi3k/Akt signaling pathway (Retraction of Vol 140, art no 103129, 2020)
Qiao, Hai-Feng
Liu, Ying-Lei
You, Jun
Zheng, Yan-Li
Chen, Li-Ping
Lu, Xiao-Yan
Du, Lei
Shan, Feng
Liu, Man-Hua
JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2022, 150
[33] RETRACTION: Effects of Glut1 gene silencing on proliferation, differentiation, and apoptosis of colorectal cancer cells by targeting the TGF-β/PI3K-AKT-mTOR signaling pathway (Retraction of Vol 119, Pg 2356, 2018)
Wu, Xue-Liang
Wang, Li-Kun
Yang, Dong-Dong
Qu, Ming
Yang, Yong-Jiang
Guo, Fei
Han, Lei
Xue, Jun
JOURNAL OF CELLULAR BIOCHEMISTRY, 2021, 122 : S101 - S101
[34] RETRACTION: Protective role of microRNA-27a upregulation and HSP90 silencing against cerebral ischemia-reperfusion injury in rats by activating PI3K/AKT/mTOR signaling pathway (Retraction of Vol 86, art no 106635, 2020)
Zhang, Ensheng
Chen, Qian
Wang, Jing
Li, Dong
Wan, Zhenxia
Ju, Xiuli
INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 99
[35] RETRACTION: miR-188-5p Promotes Tumor Growth by Targeting CD2AP Through PI3K/AKT/mTOR Signaling in Children with Acute Promyelocytic Leukemia (Retraction of Vol 13, Pg 6681, 2020)
Wang, D.
Chen, J.
Ding, Y.
ONCOTARGETS AND THERAPY, 2023, 16 : 1025 - 1026
[36] RETRACTION: Down-regulated microRNA-223 or elevated ZIC1 inhibits the development of pancreatic cancer via inhibiting PI3K/Akt/mTOR signaling pathway activation (Retraction of Vol 19, Pg 2851, 2020)
Zhu, Jian
Lv, Jian
Chen, Jing
Zhang, Xuesong
Ji, Yong
CELL CYCLE, 2022, 21 (23) : 2561 - 2561
[37] RETRACTION: Silencing of COL1A2, COL6A3, and THBS2 inhibits gastric cancer cell proliferation, migration, and invasion while promoting apoptosis through the PI3k-Akt signaling pathway (Retraction of Vol 119, Pg 4420, 2018)
Ao, Ran
Guan, Lin
Wang, Ying
Wang, Jia-Ni
JOURNAL OF CELLULAR BIOCHEMISTRY, 2021, 122 : S102 - S102
[38] RETRACTION: Long Noncoding RNA LINC003121 Inhibits Proliferation and Invasion of Thyroid Cancer Cells by Suppression of the Phosphatidylinositol-3-Kinase (PI3K)/Akt Signaling Pathway (Retraction of Vol 24, Pg LBR45, 2018)
Min, Xiang
Liu, Kai
Zhu, Hengtao
Zhang, Jian
MEDICAL SCIENCE MONITOR, 2021, 27
[39] RETRACTION: Long non-coding RNA HULC promotes bladder cancer cells proliferation but inhibits apoptosis via regulation of ZIC2 and PI3K/AKT signaling pathway (Retraction of Vol 20, Pg 425, 2017)
Wang, Jintao
Ma, Weimin
Liu, Yidong
CANCER BIOMARKERS, 2022, 35 (03) : 345 - 345
[40] RETRACTION: The Use of BT-ESD Technology under General Intravenous Anesthesia in the Treatment of Nonmuscle Invasive Bladder Cancer and the Effect of PI3K/Akt Signaling Pathway on Tumor Recurrence (Retraction of Vol 2021, art no 8860745, 2021)
Yan, H.
Xia, S.
Yao, D.
Shi, J.
Liu, Z.
BIOMED RESEARCH INTERNATIONAL, 2024, 2024

← 1 2 3 4 5 →